These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19706537)

  • 1. In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation.
    Kishimoto H; Zhao M; Hayashi K; Urata Y; Tanaka N; Fujiwara T; Penman S; Hoffman RM
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14514-7. PubMed ID: 19706537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visualization of intrathoracically disseminated solid tumors in mice with optical imaging by telomerase-specific amplification of a transferred green fluorescent protein gene.
    Umeoka T; Kawashima T; Kagawa S; Teraishi F; Taki M; Nishizaki M; Kyo S; Nagai K; Urata Y; Tanaka N; Fujiwara T
    Cancer Res; 2004 Sep; 64(17):6259-65. PubMed ID: 15342413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-selective, adenoviral-mediated GFP genetic labeling of human cancer in the live mouse reports future recurrence after resection.
    Kishimoto H; Aki R; Urata Y; Bouvet M; Momiyama M; Tanaka N; Fujiwara T; Hoffman RM
    Cell Cycle; 2011 Aug; 10(16):2737-41. PubMed ID: 21785265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Resection and Outcome of Colon-Cancer Liver Metastasis with Fluorescence-Guided Surgery Using In Situ GFP Labeling with a Telomerase-Dependent Adenovirus in an Orthotopic Mouse Model.
    Yano S; Takehara K; Miwa S; Kishimoto H; Hiroshima Y; Murakami T; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
    PLoS One; 2016; 11(2):e0148760. PubMed ID: 26849435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting tumors with a killer-reporter adenovirus for curative fluorescence-guided surgery of soft-tissue sarcoma.
    Yano S; Miwa S; Kishimoto H; Uehara F; Tazawa H; Toneri M; Hiroshima Y; Yamamoto M; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
    Oncotarget; 2015 May; 6(15):13133-48. PubMed ID: 26033451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective metastatic tumor labeling with green fluorescent protein and killing by systemic administration of telomerase-dependent adenoviruses.
    Kishimoto H; Urata Y; Tanaka N; Fujiwara T; Hoffman RM
    Mol Cancer Ther; 2009 Nov; 8(11):3001-8. PubMed ID: 19887549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced antitumor efficacy of telomerase-selective oncolytic adenoviral agent OBP-401 with docetaxel: preclinical evaluation of chemovirotherapy.
    Fujiwara T; Kagawa S; Kishimoto H; Endo Y; Hioki M; Ikeda Y; Sakai R; Urata Y; Tanaka N; Fujiwara T
    Int J Cancer; 2006 Jul; 119(2):432-40. PubMed ID: 16477640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus.
    Kishimoto H; Kojima T; Watanabe Y; Kagawa S; Fujiwara T; Uno F; Teraishi F; Kyo S; Mizuguchi H; Hashimoto Y; Urata Y; Tanaka N; Fujiwara T
    Nat Med; 2006 Oct; 12(10):1213-9. PubMed ID: 17013385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraperitoneal administration of telomerase-specific oncolytic adenovirus sensitizes ovarian cancer cells to cisplatin and affects survival in a xenograft model with peritoneal dissemination.
    Takakura M; Nakamura M; Kyo S; Hashimoto M; Mori N; Ikoma T; Mizumoto Y; Fujiwara T; Urata Y; Inoue M
    Cancer Gene Ther; 2010 Jan; 17(1):11-9. PubMed ID: 19662088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence-guided assessment of bone and soft-tissue sarcomas for predicting the efficacy of telomerase-specific oncolytic adenovirus.
    Uotani K; Tazawa H; Hasei J; Fujiwara T; Yoshida A; Yamakawa Y; Omori T; Sugiu K; Komatsubara T; Kondo H; Morita T; Kiyono M; Yokoo S; Hata T; Kunisada T; Takeda K; Urata Y; Fujiwara T; Ozaki T
    PLoS One; 2024; 19(2):e0298292. PubMed ID: 38377118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells.
    Watanabe T; Hioki M; Fujiwara T; Nishizaki M; Kagawa S; Taki M; Kishimoto H; Endo Y; Urata Y; Tanaka N; Fujiwara T
    Exp Cell Res; 2006 Feb; 312(3):256-65. PubMed ID: 16356494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoviral targeting of malignant melanoma for fluorescence-guided surgery prevents recurrence in orthotopic nude-mouse models.
    Yano S; Takehara K; Kishimoto H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
    Oncotarget; 2016 Apr; 7(14):18558-72. PubMed ID: 26701857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo imaging of human cancer with telomerase-specific replication-selective adenovirus.
    Fujiwara T
    Methods Mol Biol; 2012; 872():129-39. PubMed ID: 22700408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication of osteosarcoma by fluorescence-guided surgery with tumor labeling by a killer-reporter adenovirus.
    Yano S; Miwa S; Kishimoto H; Urata Y; Tazawa H; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
    J Orthop Res; 2016 May; 34(5):836-44. PubMed ID: 26479501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence-guided surgery of a highly-metastatic variant of human triple-negative breast cancer targeted with a cancer-specific GFP adenovirus prevents recurrence.
    Yano S; Takehara K; Miwa S; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
    Oncotarget; 2016 Nov; 7(46):75635-75647. PubMed ID: 27689331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Cell-Cycle-Decoy Efficacy of a Telomerase-Dependent Adenovirus in an Orthotopic Model of Chemotherapy-Resistant Human Stomach Carcinomatosis Peritonitis Visualized With FUCCI Imaging.
    Yano S; Takehara K; Tazawa H; Kishimoto H; Urata Y; Kagawa S; Fujiwara T; Hoffman RM
    J Cell Biochem; 2017 Nov; 118(11):3635-3642. PubMed ID: 27171483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of detecting viable circulating tumour cells in gastric cancer patients using a telomerase-specific viral agent: a prospective study.
    Ito H; Inoue H; Sando N; Kimura S; Gohda K; Sato J; Murakami K; Ito S; Odaka N; Satodate H; Kudo SE
    BMC Cancer; 2012 Aug; 12():346. PubMed ID: 22873704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental Curative Fluorescence-guided Surgery of Highly Invasive Glioblastoma Multiforme Selectively Labeled With a Killer-reporter Adenovirus.
    Yano S; Miwa S; Kishimoto H; Toneri M; Hiroshima Y; Yamamoto M; Bouvet M; Urata Y; Tazawa H; Kagawa S; Fujiwara T; Hoffman RM
    Mol Ther; 2015 Jul; 23(7):1182-1188. PubMed ID: 25896244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced oncolysis by a tropism-modified telomerase-specific replication-selective adenoviral agent OBP-405 ('Telomelysin-RGD').
    Taki M; Kagawa S; Nishizaki M; Mizuguchi H; Hayakawa T; Kyo S; Nagai K; Urata Y; Tanaka N; Fujiwara T
    Oncogene; 2005 Apr; 24(19):3130-40. PubMed ID: 15735729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OBP-401-GFP telomerase-dependent adenovirus illuminates and kills high-metastatic more effectively than low-metastatic triple-negative breast cancer in vitro.
    Yano S; Takehara K; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
    Cancer Gene Ther; 2017 Feb; 24(2):45-47. PubMed ID: 28106046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.